6.
Vural M, Ertas G, Onay A, Acar O, Esen T, Saglican Y
. Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000. Biomed Res Int. 2014; 2014:768291.
PMC: 4267000.
DOI: 10.1155/2014/768291.
View
7.
Greenberg J, Koller C, Casado C, Triche B, Krane L
. A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer. Ther Adv Urol. 2022; 14:17562872221096377.
PMC: 9073105.
DOI: 10.1177/17562872221096377.
View
8.
Tirumani S, Suh C, Kim K, Shinagare A, Ramaiya N, Fennessy F
. Head-to-head comparison of prostate MRI using an endorectal coil versus a non-endorectal coil: meta-analysis of diagnostic performance in staging T3 prostate cancer. Clin Radiol. 2019; 75(2):157.e9-157.e19.
DOI: 10.1016/j.crad.2019.09.142.
View
9.
Lee G, Oto A, Giurcanu M
. Prostate MRI: Is Endorectal Coil Necessary?-A Review. Life (Basel). 2022; 12(4).
PMC: 9030903.
DOI: 10.3390/life12040569.
View
10.
Suo S, Chen X, Wu L, Zhang X, Yao Q, Fan Y
. Non-Gaussian water diffusion kurtosis imaging of prostate cancer. Magn Reson Imaging. 2014; 32(5):421-7.
DOI: 10.1016/j.mri.2014.01.015.
View
11.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M
. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86.
DOI: 10.1002/ijc.29210.
View
12.
Hepp T, Kalmbach L, Kolb M, Martirosian P, Hilbert T, Thaiss W
. T2 mapping for the characterization of prostate lesions. World J Urol. 2022; 40(6):1455-1461.
PMC: 9166840.
DOI: 10.1007/s00345-022-03991-8.
View
13.
Roethke M, Kuru T, Radbruch A, Hadaschik B, Schlemmer H
. Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?. World J Radiol. 2013; 5(7):259-63.
PMC: 3730080.
DOI: 10.4329/wjr.v5.i7.259.
View
14.
Turkbey B, Merino M, Gallardo E, Shah V, Aras O, Bernardo M
. Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging. 2013; 39(6):1443-8.
PMC: 4016166.
DOI: 10.1002/jmri.24317.
View
15.
Ullrich T, Quentin M, Schmaltz A, Arsov C, Rubbert C, Blondin D
. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. Eur Radiol. 2017; 28(1):17-23.
DOI: 10.1007/s00330-017-4940-7.
View
16.
Plodeck V, Radosa C, Hubner H, Baldus C, Borkowetz A, Thomas C
. Rectal gas-induced susceptibility artefacts on prostate diffusion-weighted MRI with epi read-out at 3.0 T: does a preparatory micro-enema improve image quality?. Abdom Radiol (NY). 2020; 45(12):4244-4251.
PMC: 8260527.
DOI: 10.1007/s00261-020-02600-9.
View
17.
De Marini P, Cazzato R, Garnon J, Shaygi B, Koch G, Auloge P
. Percutaneous MR-guided prostate cancer cryoablation technical updates and literature review. BJR Open. 2020; 1(1):20180043.
PMC: 7592492.
DOI: 10.1259/bjro.20180043.
View
18.
Tamada T, Ream J, Doshi A, Taneja S, Rosenkrantz A
. Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging of the Prostate at 3 Tesla: Comparison With Standard Echo-Planar Imaging Technique for Image Quality and Tumor Assessment. J Comput Assist Tomogr. 2017; 41(6):949-956.
DOI: 10.1097/RCT.0000000000000634.
View
19.
Bao J, Wang X, Hu C, Hou J, Dong F, Guo L
. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI. Eur J Radiol Open. 2017; 4:123-128.
PMC: 5633348.
DOI: 10.1016/j.ejro.2017.08.003.
View
20.
Barentsz J, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G
. ESUR prostate MR guidelines 2012. Eur Radiol. 2012; 22(4):746-57.
PMC: 3297750.
DOI: 10.1007/s00330-011-2377-y.
View